share_log

Hims & Hers Health | 8-K: Current report

ヒムズ&ハーズヘルス | 8-K:臨時報告書

SEC ·  2024/06/10 13:45

Moomoo AIのまとめ

Hims & Hers Health held its Annual Meeting of Stockholders on June 6, 2024, where shareholders voted on three key proposals. All eight nominated directors, including CEO Andrew Dudum and medical experts Dr. Patrick Carroll and Dr. Delos Cosgrove, were successfully elected to serve until the 2025 annual meeting.Stockholders overwhelmingly approved the appointment of KPMG LLP as the company's independent registered public accounting firm for fiscal year 2024, with 1.59 billion votes in favor. Additionally, shareholders provided advisory approval for the company's executive compensation package, receiving 1.51 billion supporting votes.The voting process involved both Class A Common Stock (one vote per share) and Class V Common Stock (175 votes per share) holders, with a total of 206,271,215 Class A shares and 8,377,623 Class V shares eligible to vote as of the April 16, 2024 record date.
Hims & Hers Health held its Annual Meeting of Stockholders on June 6, 2024, where shareholders voted on three key proposals. All eight nominated directors, including CEO Andrew Dudum and medical experts Dr. Patrick Carroll and Dr. Delos Cosgrove, were successfully elected to serve until the 2025 annual meeting.Stockholders overwhelmingly approved the appointment of KPMG LLP as the company's independent registered public accounting firm for fiscal year 2024, with 1.59 billion votes in favor. Additionally, shareholders provided advisory approval for the company's executive compensation package, receiving 1.51 billion supporting votes.The voting process involved both Class A Common Stock (one vote per share) and Class V Common Stock (175 votes per share) holders, with a total of 206,271,215 Class A shares and 8,377,623 Class V shares eligible to vote as of the April 16, 2024 record date.
これらの内容は、情報提供及び投資家教育のためのものであり、いかなる個別株や投資方法を推奨するものではありません。 更に詳しい情報